AbbVie to Advance Once-Daily ABT-494 to Phase 3 in Rheumatoid Arthritis by Year-End

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. KKR
2. ORCL
3. LLY
4. DAVA
5. MONC:IM
6. MONRY
7. NYXH
8. TDY
9. PNR
10. ACN

Go back to AbbVie to Advance Once-Daily ABT-494 to Phase 3 in Rheumatoid Arthritis by Year-End
AbbVie (NYSE: ABBV) Delayed: 264.48 --0 (-0%)
Previous Close $264.48    52 Week High $68.12 
Open $264.48    52 Week Low $50.71 
Day High $264.48    P/E 57.37 
Day Low $264.48    EPS $4.61 
Volume 1,829